Lupin signs supply deal to launch antidepressant in Canada

Drug firm Lupin has partnered with Spektus Pharma. They will commercialise the antidepressant DeslaFlex in Canada. This collaboration combines Lupin's Canadian presence with Spektus's formulation expertise. It aims to offer patients more personalized care for Major Depressive Disorder. The deal strengthens Lupin's central nervous system portfolio. Lupin shares saw a slight increase on Monday.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/kMS69A4
via IFTTT